Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07615465 · ClinicalTrials.gov registry record · NA
An Osseointegrated Transfemoral Prosthesis Offering Long-Term Bi-Directional Efferent-Afferent Neural Transmission
A NA study, sponsored by Massachusetts Institute of Technology.
- Active
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT07615465: Active NA study, sponsored by Massachusetts Institute of Technology.
NCT07615465 is a NA study that is active but no longer recruiting, run by Massachusetts Institute of Technology. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07615465, a NA study, is active but no longer recruiting, sponsored by Massachusetts Institute of Technology.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate the clinical and functional outcomes of a transfemoral amputation with osseointegrated titanium implant, AMI muscle constructs, and implanted electrodes in the domain of gait, free space control, and embodiment.
Primary Outcome
Quantitative analysis of joint angles, during level-ground walking, stair negotiation, and other functional tasks. Outcomes will be assessed using a motion capture system (e.g., Vicon) and embedded prosthesis sensors.
Interventions
- DEVICE MIT Powered Knee Prosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-04-15 |
| Est. Completion | 2026-07-17 |
| Phase | NA |
What the registry record for NCT07615465 still lists
NCT07615465 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which MIT Powered Knee Prosthesis is the first listed.
NCT07615465 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07615465 about?
NCT07615465 is a clinical study titled "An Osseointegrated Transfemoral Prosthesis Offering Long-Term Bi-Directional Efferent-Afferent Neural Transmission". The purpose of the study is to investigate the clinical and functional outcomes of a transfemoral amputation with osseointegrated titanium implant, AMI muscle constructs, and implanted electrodes in the domain of gait, free space control, and embodiment.
What is the current status of trial NCT07615465?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 2 participants. The study started on 2017-04-15. Estimated completion is 2026-07-17.
What interventions are being tested in trial NCT07615465?
The interventions under investigation include: MIT Powered Knee Prosthesis (DEVICE).
Who is sponsoring clinical trial NCT07615465?
This trial is sponsored by Massachusetts Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07615465's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI